BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18194985)

  • 1. Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice.
    Glauben R; Batra A; Stroh T; Erben U; Fedke I; Lehr HA; Leoni F; Mascagni P; Dinarello CA; Zeitz M; Siegmund B
    Gut; 2008 May; 57(5):613-22. PubMed ID: 18194985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC inhibitors in models of inflammation-related tumorigenesis.
    Glauben R; Sonnenberg E; Zeitz M; Siegmund B
    Cancer Lett; 2009 Aug; 280(2):154-9. PubMed ID: 19101082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone hyperacetylation is associated with amelioration of experimental colitis in mice.
    Glauben R; Batra A; Fedke I; Zeitz M; Lehr HA; Leoni F; Mascagni P; Fantuzzi G; Dinarello CA; Siegmund B
    J Immunol; 2006 Apr; 176(8):5015-22. PubMed ID: 16585598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species.
    Denlinger CE; Rundall BK; Jones DR
    J Thorac Cardiovasc Surg; 2004 Nov; 128(5):740-8. PubMed ID: 15514602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis.
    Nam SY; Kim JS; Kim JM; Lee JY; Kim N; Jung HC; Song IS
    Exp Biol Med (Maywood); 2008 Feb; 233(2):180-91. PubMed ID: 18222973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death.
    Rundall BK; Denlinger CE; Jones DR
    Surgery; 2004 Aug; 136(2):416-25. PubMed ID: 15300209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apple polysaccharide reduces NF-Kb mediated colitis-associated colon carcinogenesis.
    Zhang D; Mi M; Jiang F; Sun Y; Li Y; Yang L; Fan L; Li Q; Meng J; Yue Z; Liu L; Mei Q
    Nutr Cancer; 2015; 67(1):177-90. PubMed ID: 25412264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of NF-κB: bridging the gap between inflammation and cancer in colitis-mediated colon carcinogenesis.
    Setia S; Nehru B; Sanyal SN
    Biomed Pharmacother; 2014 Feb; 68(1):119-28. PubMed ID: 24269000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits anti-inflammatory activities through induction of mitochondrial damage and apoptosis in activated lymphocytes.
    Shi ZJ; Ouyang DY; Zhu JS; Xu LH; He XH
    Int Immunopharmacol; 2012 Apr; 12(4):580-7. PubMed ID: 22369900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis.
    Schmidt N; Gonzalez E; Visekruna A; Kühl AA; Loddenkemper C; Mollenkopf H; Kaufmann SH; Steinhoff U; Joeris T
    Gut; 2010 Jul; 59(7):896-906. PubMed ID: 20581238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.
    De Vry CG; Prasad S; Komuves L; Lorenzana C; Parham C; Le T; Adda S; Hoffman J; Kahoud N; Garlapati R; Shyamsundar R; Mai K; Zhang J; Muchamuel T; Dajee M; Schryver B; McEvoy LM; Ehrhardt RO
    Gut; 2007 Apr; 56(4):524-33. PubMed ID: 16950831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.
    Sugimoto K; Hanai H; Tozawa K; Aoshi T; Uchijima M; Nagata T; Koide Y
    Gastroenterology; 2002 Dec; 123(6):1912-22. PubMed ID: 12454848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anti-inflammatory action of 5-aminoimidazole-4-carboxamide ribonucleoside with protective effect in dextran sulfate sodium-induced acute and chronic colitis.
    Bai A; Yong M; Ma AG; Ma Y; Weiss CR; Guan Q; Bernstein CN; Peng Z
    J Pharmacol Exp Ther; 2010 Jun; 333(3):717-25. PubMed ID: 20237071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
    Imre G; Gekeler V; Leja A; Beckers T; Boehm M
    Cancer Res; 2006 May; 66(10):5409-18. PubMed ID: 16707469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxyamidotriazole ameliorates experimental colitis by inhibition of cytokine production, nuclear factor-κB activation, and colonic fibrosis.
    Guo L; Ye C; Hao X; Zheng R; Ju R; Wu D; Luo L; Wang C; Li J; Yu X; Zhu L; Zhang D
    J Pharmacol Exp Ther; 2012 Aug; 342(2):356-65. PubMed ID: 22553216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitors exert time-dependent effects on nuclear factor-kappaB but consistently suppress the expression of proinflammatory genes in human myometrial cells.
    Lindström TM; Mohan AR; Johnson MR; Bennett PR
    Mol Pharmacol; 2008 Jul; 74(1):109-21. PubMed ID: 18375836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
    Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines.
    Yasui Y; Hosokawa M; Mikami N; Miyashita K; Tanaka T
    Chem Biol Interact; 2011 Aug; 193(1):79-87. PubMed ID: 21621527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ITF2357 interferes with apoptosis and inflammatory pathways in the HL-60 model: a gene expression study.
    Galimberti S; Canestraro M; Savli H; Palumbo GA; Tibullo D; Nagy B; Piaggi S; Guerrini F; Cine N; Metelli MR; Petrini M
    Anticancer Res; 2010 Nov; 30(11):4525-35. PubMed ID: 21115902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
    Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O
    Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.